Literature DB >> 20180886

Clinical and immunopathological spectrum of paraneoplastic pemphigus.

Jutta Zimmermann1, Friedrich Bahmer, Christian Rose, Detlef Zillikens, Enno Schmidt.   

Abstract

BACKGROUND: Paraneoplastic pemphigus (PNP) is a rare life-threatening autoimmune bullous disorder. The clinical picture is often polymorphous and blisters may be absent. Autoantibodies are directed against several target antigens, including plakins and desmogleins. PNP has a high mortality rate that does not directly depend on the malignancy of the neoplasm. No generally accepted diagnostic criteria for PNP have been defined. PATIENTS AND METHODS: On the basis of four selected PNP patients and the relevant literature, the spectrum of clinical and immunopathological findings as well as pathogenesis and treatment options of PNP are presented.
RESULTS: In addition to a neoplasm, severe stomatitis and the presence of autoantibodies against periplakin and envoplakin are characteristic for PNP. Based on the presented data, diagnostic criteria are proposed.
CONCLUSIONS: Knowledge of the polymorphous clinical picture and the complex autoantibody response is essential for an early diagnosis of PNP which has implications for both prognosis and rapid initiation of treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20180886     DOI: 10.1111/j.1610-0387.2010.07380.x

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  23 in total

Review 1.  The diagnosis and treatment of autoimmune blistering skin diseases.

Authors:  Enno Schmidt; Detlef Zillikens
Journal:  Dtsch Arztebl Int       Date:  2011-06-10       Impact factor: 5.594

Review 2.  Autoimmune Blistering Diseases in the Elderly: Clinical Presentations and Management.

Authors:  Minhee Kim; Luca Borradori; Dédée F Murrell
Journal:  Drugs Aging       Date:  2016-10       Impact factor: 3.923

Review 3.  [Paraneoplastic autoimmune dermatoses].

Authors:  D Didona; M Hertl
Journal:  Hautarzt       Date:  2021-03-01       Impact factor: 0.751

Review 4.  Pemphigus group: overview, epidemiology, mortality, and comorbidities.

Authors:  Khalaf Kridin
Journal:  Immunol Res       Date:  2018-04       Impact factor: 2.829

5.  Features and Risk Factors for Paraneoplastic Autoimmune Multiorgan Syndrome in 145 Chinese Patients.

Authors:  Mingyue Wang; Furong Li; Xintong Wang; Xue Wang; Rui Wang; Yinmo Yang; Jian Li; Shijie Zhang; Weiming Huang; Yujun Dong; Xiangdong Mu; Ting Li; Kaiwen Ni; Xixue Chen; Xuejun Zhu
Journal:  Acta Derm Venereol       Date:  2020-11-04       Impact factor: 3.875

Review 6.  Paraneoplastic pemphigus: a short review.

Authors:  Marta Wieczorek; Annette Czernik
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-09-23

Review 7.  Paraneoplastic Pemphigus: Insight into the Autoimmune Pathogenesis, Clinical Features and Therapy.

Authors:  Giovanni Paolino; Dario Didona; Giuseppe Magliulo; Giannicola Iannella; Biagio Didona; Santo Raffaele Mercuri; Elisa Moliterni; Michele Donati; Andrea Ciofalo; Guido Granata; Patricia Ranuzzi; Vincenzo Falasca; Stefano Calvieri
Journal:  Int J Mol Sci       Date:  2017-11-26       Impact factor: 5.923

Review 8.  Bullous Autoimmune Dermatoses–Clinical Features, Diagnostic Evaluation, and Treatment Options.

Authors:  Nina van Beek; Detlef Zillikens; Enno Schmidt
Journal:  Dtsch Arztebl Int       Date:  2021-06-18       Impact factor: 8.251

Review 9.  Non-classical forms of pemphigus: pemphigus herpetiformis, IgA pemphigus, paraneoplastic pemphigus and IgG/IgA pemphigus.

Authors:  Adriana Maria Porro; Livia de Vasconcelos Nasser Caetano; Laura de Sena Nogueira Maehara; Milvia Maria dos Santos Enokihara
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

10.  Sequence-specific 1H, 13C and 15N backbone resonance assignments of the plakin repeat domain of human envoplakin.

Authors:  Mark Jeeves; Claudia Fogl; Caezar Al-Jassar; Martyn Chidgey; Michael Overduin
Journal:  Biomol NMR Assign       Date:  2015-11-21       Impact factor: 0.746

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.